/Investor DB

Viking Global Investors — Full Portfolio

62 tracked investments · listed companies and verified rows first

4D Molecular Therapeutics4dmoleculartherapeutics.cominNASDAQ: FDMTJun 2020 · $75M

4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases.

BiotechHealthtechEmeryville, US

David Kirn(Executive Officer, Director)inDavid Schaffer(Director)inTheresa Janke(Executive Officer)in

BoardSharon Tetlow(Director)Margi McLoughlin(Director)

Co-investorsAmzak HealthBerkeley CatalystBOLD LongevityChiesi VenturesPappas CapitalPfizer Venture Investments+7 more

aTYR PHARMAatyrpharma.comin𝕏NASDAQ: ATYR

aTyr is a clinical-stage biotechnology company developing therapies derived from tRNA synthetase biology to treat fibrosis and inflammation, with its lead candidate efzofitimod in clinical trials for interstitial lung disease.

BiotechHealthtechMedical DevicesSan Diego, US

Paul Schimmel(Founder)John D. Mendlein(Executive Officer, Director)David Weiner(Executive Officer)inFrederic Chereau(Executive Officer)

BoardAmir Nashat(Non-Management Director)inAkkaraju Srinivas(Non-Management Director)

Co-investorsCardinal PartnersEcoR1 CapitalSofinnova VenturesViking GlobalDomain AssociatesDomain Partners+2 more

Damora TherapeuticsNASDAQ: DMRANov 2025 · $284.9M

Damora Therapeutics is a preclinical-stage biotechnology company that discovers and develops therapeutic candidates, including DMR-001, DMR-002, and DMR-003, with the goal of advancing treatments through investigational drug applications and clinical trials.

BiotechCopenhagen, US

Garrett Winslow(Executive Officer)inLori Firmani(Executive Officer)inHans T. Schambye(Executive Officer, Director)Jennifer Jarrett(President, Chief Executive Officer and Director)inBecker Hewes(Chief Medical Officer)Sherwin Sattarzadeh(Chief Operating Officer)

Co-investorsAccess BiotechnologyViking GlobalAndreessen HorowitzBAM ElevateBay City CapitalCommodore Capital+8 more

Domodomo.comin𝕏NASDAQ: DOMOFeb 2014

Domo offers a cloud-based platform that integrates data integration, analytics, automation, and artificial intelligence capabilities to help organizations connect data sources, prepare and analyze information, and automate business processes and workflows.

Enterprise SoftwareSaaSAmerican Fork, US

Josh James(Founder)inShane Atchison(Executive Officer)inMatt Belkin(Executive Officer)inBruce Felt(Executive Officer)inDaren Thayne(Chief Technology Officer & Executive Vice President of Product)inTod Crane(Chief Financial Officer)in

Co-investors3Spoke CapitalAlumni VenturesAndreessen HorowitzBlackRockBlue Ivy VenturesCapital Group+14 more

Ginkgo Bioworksginkgo.bioin𝕏NYSE: DNAJul 2015

Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.

AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US

Jason Kelly(Founder)inReshma Shetty(Founder)inBarry Canton(Founder)inAustin Che(Founder)inTom Knight(Founder)inBartholomew Canton(Executive Officer)

Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+62 more

Allonniaallonnia.comin𝕏Jul 2023 · $30M

Allonnia applies industrial biology—screening microbes and engineered proteins that interact with metals—to recover copper, nickel, and rare earths from ore and mine waste streams like coal ash, tailings, and acid mine drainage.

BiotechCleantechNew MaterialsBoston, US

Nicole Richards(CEO)inKent Sorenson(Chief Technology Officer)inChuck(Executive)inPamela(Head of Human Resources)inHugh(Financial Leadership)in

BoardTom Biegala(Director)in

Co-investorsBison VenturesGeneral AtlanticViking GlobalBHP VenturesFerment StudioVale Ventures

AlphaSensealpha-sense.comin𝕏Aug 2015

AlphaSense provides a financial research and market intelligence platform that combines standardized financials, consensus estimates, filings, earnings transcripts, broker research, and AI-generated answers for analyzing and benchmarking companies.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechNew York, US

Rajmohan Neervannan(Related person at the time of the offering.)Raj Neervannan(Founder)inJaakko (Jack) Kokko(Founder)inJack Kokko(Founder)inKiva Kolstein(President & Chief Revenue Officer)inHeather Zynczak(Chief Marketing Officer)in

Co-investorsAlkeon InnovationBlue Owl CapitalBond Capital ManagementBrama One VenturesCapitalGCentana Growth Partners+11 more

Amunix Pharmaceuticalsamunix.comMar 2021 · $117M

Biopharmaceutical company discovering and developing novel biologics, protein, and peptide therapeutics.

BiotechSouth San Francisco, US

Trisha Millican(Director)James Topper(Director)Otello Stampacchia(Director)David Hirsch(Director)Volker Schellenberger(Executive Officer)James Brush(Director)

Co-investorsBain Capital Life SciencesFrazier Life SciencesLongitude CapitalViking GlobalBlackRockCasdin Capital+6 more

Apeel Sciencesapeel.comin𝕏Aug 2021

Apeel Sciences develops plant-based coatings derived from fatty acids and glycerides—ingredients naturally found in plant peels and seeds—that are applied to fresh fruits and vegetables to extend shelf life, preserve flavor and nutrients, and reduce reliance on refrigeration, pesticides, waxes, and plastics.

AgTechCircular EconomyCleantechClimate TechFoodTech

LouJames Rogers(Founder)inJenny Du(Founder)in

Co-investors3cubed VenturesA-Rod CorpAgFunderAndreessen HorowitzATEL VenturesBild Alternative Investments Corporation+20 more

Areteia Therapeuticsareteiatx.cominFeb 2024Defunct

Areteia Therapeutics was a clinical-stage biotechnology company that is no longer operating.

BiotechChapel Hill, US

Robin Walker(Executive Officer)inChristopher Courts(Executive Officer)inJorge Bartolome(Founder)in

BoardBenjamin Gomez(Director)Adam Koppel(Director)inMichael E. Bozik(Director)

Co-investorsARCH Venture PartnersBain Capital Life SciencesGV (Google Ventures)Solas BioVenturesViking GlobalAccess Biotechnology+3 more

Asset Watchassetwatch.comin𝕏May 2025 · $75M

AssetWatch provides cloud-based asset monitoring software and sensor technology to help manufacturing and industrial facilities prevent unplanned equipment downtime.

Advanced ManufacturingEnterprise SoftwareIoTSaaSWesterville, US

William Zell(Executive Officer, Director)William Ruff(Executive Officer)inRobert Lee(Director)inTad Dritz(VP of Development)inJeff Haskett(COO)inBrian Graham(Executive Officer, Director)in

Co-investorsCerity Partners VenturesG2 Venture PartnersHarmonic Growth PartnersJobsOhio VenturesMonte Carlo CapitalOUP (Osage University Partners)+4 more

Athiraathira.comJun 2020 · $85M

A biotechnology company developing new therapies for patients with high unmet medical needs.

Biotech

Co-investorsDolby Family VenturesLifeSci Venture PartnersSofinnova VenturesThe W FundViking GlobalCommodore Capital+6 more

Aurisaurisgestion.com

Auris Gestion is an independent asset management firm offering asset allocation and wealth management services across three activities serving independent financial advisors and family offices, institutional clients, and private clients.

Fintech

Co-investorsAndera PartnersMithril Capital ManagementCoatue ManagementLux Capital

Auris Healthaurishealth.comJan 2019 · $220M

Developer of a surgical robotic system for minimally invasive endoscopy and laparoscopy

Frederic Moll(Founder)

Co-investorsBeast VenturesLux CapitalMithril Capital ManagementPractica CapitalSBI Investment Korea Co. Ltd.Sonder Capital+5 more

Biome Makersbiomemakers.comAug 2021 · $15M

Biome Makers is an AgTech company that uses DNA sequencing and its BeCrop technology to analyze soil microbiome data and deliver soil health intelligence for yield limitations, disease diagnosis, and input product evaluation.

AgTechAI & Machine LearningBiotechWest Sacramento, US

Adrian Ferrero(Executive Officer, Director)in

Co-investorsLocalGlobeJME VenturesProsus VenturesPymwymicSeaya

Biosynthetic Technologiesbiosynthetic.cominJun 2025 · $56M

Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.

Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US

Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)

BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)

Co-investorsHG VenturesAthosCivilization Ventures Management, LlcGlobal Health Investment CorporationIn-Q-TelSherpalo Ventures

Cazoocazoo.co.ukFeb 2022 · $630MAcquired

Cazoo is a UK online used-car marketplace and classified advertising business, now owned by MOTORS after its 2024 administration.

London, GB

Alex Chesterman(Founder)

Co-investorsAssurant VenturesAutotech VenturesCherry VenturesDIP CapitalEight Roads VenturesEntrée Capital+15 more

Checkerspotcheckerspot.cominApr 2019 · $13M

Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.

BiotechClimate TechFoodTechNew MaterialsAlameda, US

Scott Franklin(Executive Officer, Director)inCharles Dimmler(Executive Officer, Director)inJohn Krzywicki(CEO)inLayla Ward(CFO)inCasey Lippmeier(CTO)inLeon Parker(SVP, Molecular Biology)in

Co-investorsBaruch Future VenturesBreakout VenturesCavallo VenturesPlug and Play VenturesViking GlobalBuilders VC+5 more

City Therapeuticscitytx.comin𝕏Jun 2026

City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.

BiotechMedical DevicesCambridge, US

Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in

Co-investorsAN Venture PartnersARCH Venture PartnersSofinnova VenturesViking GlobalAltitude Ventures Management, LlcCasdin Capital+5 more

Cloudbedscloudbeds.comin𝕏Nov 2021 · $150M

Cloudbeds provides a property management system (PMS) and growth platform for hospitality businesses, including hotels and other accommodations.

Cloud ComputingPropTechSaaSTravel & Hospitality

Co-investorsClearVision EquityCounterpart VenturesKeshif VenturesMoore Venture PartnersPasadena AngelsPeakSpan Capital Partners+5 more

Color Healthcolor.comin𝕏Nov 2021 · $100M

Color Health operates a nationwide virtual cancer clinic delivering oncologist-led care, screening, and treatment management for employer, union, health plan, and public sector populations.

AI & Machine LearningDigital HealthHealthtechSan Francisco, US

Othman Laraki(Founder)inElad Gil(Founder)Nish Bhat(Founder)Taylor Sittler(Founder)

Co-investors8VCAliya Capital PartnersComcast VenturesCRV (Charles River Ventures)Dria VenturesForesite Capital+14 more

Credit Karmacreditkarma.comin𝕏Jun 2015 · $175MAcquired

Credit Karma is an AI-powered personal finance platform that provides free credit scores, credit monitoring, cashflow insights, and financial marketplace services to help consumers understand and manage their finances.

AI & Machine LearningConsumerFintechSan Francisco, US

Kenneth Lin(Founder)inNichole Mustard(Founder)inRyan Graciano(Founder)inKen Lin(Founder)

Co-investors500 GlobalArcher Capital GroupArcher Venture CapitalCapitalGEQUIAMFelicis Ventures+11 more

Decipheradeciphera.comin𝕏

Deciphera is a pharmaceutical company focused on developing treatments for people living with cancer.

Biotech

Daniel Flynn(Founder)in

Co-investorsFrazier Life SciencesNew Leaf Venture PartnersREDMILE

Deciphera PharmaceuticalsinMay 2017

Develops selective kinase inhibitors for cancer (QINLOCK); acquired by Ono Pharmaceuticals in 2024.

BiotechWaltham, US

Daniel F. Flynn, Ph.D.(Executive Officer)Oliver Rosen, M.D.(Executive Officer)inThomas Kelly(Executive Officer)Michael Taylor(Executive Officer, Director)in

BoardMichael Ross(Director)Liam Ratcliffe, M.D., Ph.D.(Director)

Co-investorsFrazier Life SciencesViking GlobalREDMILE

Dockdock.usinMay 2022

Dock provides a white-label customer portal platform that enables companies to manage projects, share files, track engagement, and handle renewals in a single collaborative workspace.

AI & Machine LearningEnterprise SoftwareSaaSSales Tech

Co-investorsCraft VenturesFive Four VenturesFjor FoundersOperator CollectiveRecall CapitalHearst Ventures+6 more

Dockdock.techinMay 2022

Dock provides cloud-native payments and banking infrastructure that lets companies offer digital accounts, branded (white label) cards, Pix, acquiring, and anti-fraud/identity verification services.

Data & InfrastructureFintechSaaS

Co-investorsConfraparLightrockRiverwood CapitalViking Global

Docktrydock.ai𝕏May 2022

Dock is a collaborative workspace where users create teams of specialized AI agents that coordinate with one another to carry out departmental work.

AI & Machine LearningEnterprise SoftwareSan Francisco, US

Govind Kavaturi(Co-Founder)inMike Molinet(CEO)inAntonio Soares(Founder)Diogo Frenkel(Founder)

Co-investorsPioneerVela PartnersWSSY CombinatorAmino CapitalBlast.Club+8 more

Druvadruva.comin𝕏Jun 2019 · $147M

Druva provides a cloud-native SaaS platform for data backup, protection, recovery, and AI-driven data insights across enterprise data and workloads.

Cloud ComputingCybersecuritySaaSSunnyvale, US

Milind Borate(Founder)inJaspreet Singh(Founder)inMahesh Patel(Executive Officer)inEugenia Buzogly(Executive Officer)Ramani Kothandaraman(Founder)

BoardShailendra Jit Singh(Director)in

Co-investorsArbor Ventures UKDell Technologies CapitalFounders Circle CapitalHercules Capital, Inc.IAN GroupLightspeed India Partners+12 more

Ecovativeecovative.cominJun 2023 · $30M

Ecovative grows whole-cut meat alternatives and leather-like materials from mycelium using its AirMycelium indoor cultivation platform, which integrates with existing mushroom farming infrastructure.

BiotechFoodTechNew MaterialsGreen Island, US

Eben Bayer(Cofounder)inGavin McIntyre(Founder)in

BoardEvan Lodes(Director)Jerry Weinstein(Director)Charles Deull(Director)Jessica Harris(Director)

Co-investorsBreakout LabsBreakout VenturesCool Climate CollectiveStray Dog CapitalTrousdale VenturesViking Global+3 more

Eidos Therapeuticseidostx.com𝕏Apr 2018Acquired

A digital health resource platform providing medical professionals with educational information and clinical resources about transthyretin amyloid cardiomyopathy (ATTR-CM) and related cardiac and neurological conditions.

BiotechDigital HealthHealthtechSan Francisco, US

NEIL KUMAR(Executive Officer, Director)JONATHAN FOX(Executive Officer)UMA SINHA(Executive Officer)CHRISTINE SIU(Executive Officer)HOYOUNG HUH(Director)ERIC AGUIAR(Director)

Co-investorsAisling CapitalForesite CapitalRA CapitalViking Global

Ensomaensoma.comMay 2023 · $50M

Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.

BiotechHealthtechMedical DevicesBoston, US

Albert Seymour(Director)

BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in

Co-investors5AM VenturesAju IB InvestmentCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+10 more

Enviseenvise.ioinMay 2021 · $80M

Envise provides interactive real estate solutions and property management tools for real estate companies and their customers throughout the property lifecycle.

PropTechSaaS

Anna Nordström(CEO)in

Co-investorsRound2 Capital PartnersFidelity InvestmentsGV (Google Ventures)T. Rowe Price

EpiBiomeepibiome.comOct 2015

BiotechSouth San Francisco, US

Aaron Tynes Hammack(Executive Officer, Director)Nicholas Conley(Executive Officer, Director)

BoardPing-Chuan Tsai(Director)

Co-investorsStartXAlexandriaMatrix Capital ManagementSv Tech Ventures, Inc.

HI-Biohibio.comJan 2024acquired by Biogen

Biotech company developing antibodies to treat autoimmune and inflammatory diseases.

Co-investorsAlpha Wave GlobalArkin CapitalArkin Digital HealthJeito CapitalMonograph Capital PartnersViking Global+1 more

Impossible Foodsimpossiblefoods.comin𝕏Aug 2017 · $75M

Impossible Foods produces plant-based meat alternatives, including beef, pork, chicken, and sausage products designed to replicate the taste, nutrition, and cooking properties of conventional animal meat.

ConsumerFoodTechHealthtechRedwood City, US

Pat Brown(Founder)inDavid Lee(Executive Officer)inPeter McGuinnessinPatrick O. Brown(Founder)in

BoardBart Swanson(Director)inSamir Kaul(Director)in

Co-investors1435 CapitalAliya Capital PartnersAllied Venture PartnersAngelDAOBlue Horizon CorporationBVP Investors+32 more

Keboolakeboola.comin𝕏Dec 2023

Keboola provides a data platform that helps organizations turn data into reliable decisions.

AI & Machine LearningClimate TechCloud ComputingData & InfrastructureFintechSaaS

Petr Simecek(Founder)inMarek Streibl(Founder)Milan Vesely(Founder)

Co-investorsPresto VenturesReflex CapitalViking GlobalTCF Capital

Kinnate Biopharmakinnate.comDec 2019

BiotechSan Diego, US

Stephen W. Kaldor(Executive Officer, Director, Promoter)Eric Murphy(Executive Officer, Director)

BoardBret Zbar(Director)Carl Gordon(Director)Michael Rome(Director)in

Co-investorsForesite CapitalNextech InvestViking GlobalJanus Henderson InvestorsRA CapitalVenrock Healthcare Capital Partners

Latitude Healthlatitudehealth.comJan 2023 · $75M

Latitude Health builds AI-driven technology for utilization management (UM), including intake and triage, clinical review, and performance insights, designed with UM leaders and clinicians.

AI & Machine LearningDigital HealthHealthtechSan Francisco, US

Chuck Feerick(Founder)inGuru Nadiger(Founder)inJarred Bressner(Director)Chris Palmieri(Director)

Co-investorsAlleyCorp

Lightmatterlightmatter.comin𝕏Jul 2026

Lightmatter is a product development firm that partners with companies to design and build digital products from concept through launch.

Developer ToolsHealthtechSaaSMountain View, US

Greg Hausheer(CEO and Founder)inBen Beecher(CTO and Founder)inNicholas Harris(Founder)inThomas Graham(Founder)inTrevor Moorman(COO)inMollie Fleury(Chief of Staff)in

Co-investorsGV (Google Ventures)Spark CapitalFidelity InvestmentsLockheed Martin VenturesT. Rowe Price

Mainstaymainstay.comin𝕏Feb 2024

Mainstay provides an AI-powered platform that enables higher education institutions to engage students through proactive, personalized coaching and messaging.

AI & Machine LearningEdTechHR TechSaaSArlington, US

Andrew Magliozzi(Founder)inKirk Daulerio(Co-Founder, Vice President, Community)in

BoardKEVIN TALBOT(Director)

Co-investorsAlumni VenturesBisk VenturesEastward Capital PartnersFundersClubK Street CapitalMichelson 20MM Foundation+12 more

Mainstay Medicalmainstay-medical.cominFeb 2024

Irish company developing an advanced neurostimulation device.

HealthtechPlymouth, US

Dan Sachs(Director)Peter Crosby(Executive Officer, Director)inJason Hannonin

BoardManus Rogan(Director)inAntoine Papiernik(Director)in

Co-investorsFountain Healthcare PartnersIreland Strategic Investment FundSeventure PartnersSofinnova PartnersViking GlobalAlly Bridge Group+1 more

Mantra Biomantrabio.cominJan 2023 · $9M

San Francisco, US

Catherine Planey(Executive Officer, Director)Alexander Mok(Executive Officer, Director)

BoardFrancisco Gimenez(Director)in

Co-investorsBoxGroupGaingelsMana VenturesNat Turner8VCAllen & Company+1 more

MyForest Foodsmyforestfoods.cominApr 2021 · $40M

MyForest Foods produces farm-grown mycelium as a new whole-food category, developing plant-based food products aimed at consumers seeking nutritious and environmentally friendly options.

AgTechBiotechClimate TechFoodTechGreen Island, US

Eben Bayer(Co-Founder & Board Chair)inPatricia Strickland(Executive Officer)Stephen Lomnes(Executive Officer)inDeb Battista(Chief Growth Officer)inDebra Antonelli(Chief People Officer)

BoardShally Shanker(Director)in

Co-investorsStray Dog CapitalUnovis Asset ManagementViking GlobalAiiM PartnersFootPrint Coalition

Neurona Therapeuticsneuronatherapeutics.cominApr 2025 · $102M

Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.

BiotechDeep TechHealthtechSouth San Francisco, US

Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)inCatherine Priest(Chief Development Officer)inGautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)

Co-investorsBerkeley FrontierIaso VenturesThe Column GroupViking GlobalYsios CapitalAlexandria+8 more

Pearl Healthpearlhealth.comJul 2026 · $50M

Pearl Health provides tools, intelligence, and support to primary care providers and healthcare organizations to deliver proactive care within value-based care models.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechNew York, US

Michael Kopko(Founder)inAnkit Patel(Founder)

BoardJeffrey De Flavio(Executive Chairman)inVineeta Agarwala(Director)inScott Kupor(Director)inJeff DeFlavio(Director)in

Co-investorsAndreessen HorowitzAlleyCorpAlumni VenturesBasecamp FundFloating PointGaingels+6 more

Pragma Biopragmabio.comMar 2023 · $10M

Computational microbiome analysis platform for immunologic disorders

Kareem Barghouti(Founder)inMohamed Donia(Founder)in

Co-investors3CC | Third Culture CapitalGood AI CapitalHarmonix FundIaso VenturesJoyance PartnersMerck Global Health Innovation Fund+5 more

Solarea Biosolareabio.cominMay 2023 · $15M

Solarea Bio develops plant-sourced living synbiotics (probiotics plus prebiotics) as medical foods targeting inflammatory conditions, starting with bone loss in women with osteopenia.

BiotechHealthtechWellness & FitnessWaltham, US

ILISSA LARIMORE(Executive Officer)inGERARDO TOLEDO(Executive Officer, Director)ERIC SCHOTT(Executive Officer)

BoardANULA JAYASURIYA(Director)inMATTHEW WALKER(Director)inNEAL BHADKAMKAR(Director)in

Co-investorsJoyance PartnersOlive Tree CapitalRising TideBold Capital PartnersDigitalDx VenturesGISEV Family Office+2 more

Star Therapeuticsstar-therapeutics.comSep 2025

Star Therapeutics develops treatments aimed at addressing real-world patient needs.

BiotechSouth San Francisco, US

Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in

Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesViking Global+11 more

Talaris Therapeuticstalaristx.comSep 2020

Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions

BiotechLouisville, US

Suzanne Ildstad(Executive Officer, Director)Scott Requadt(Executive Officer, Director)Geoff Mackay(Director)Francois Nader(Director)

BoardSandip Agarwala(Director)inMark McDade(Director)in

Co-investorsAisling CapitalKeyhorse CapitalLongitude CapitalQiming Venture Partners USAViking GlobalBlackstone Life Sciences+3 more

Trivenitriveni.bioinOct 2024 · $115M

Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.

BiotechDigital HealthHealthtech

Vishal Patelin

Co-investorsAscenta CapitalAtlas VentureBorealis VenturesBorealis VenturesMagnetic VenturesOrbiMed+4 more

Vets First Choicevetsfirstchoice.cominJul 2017 · $223M

Covetrus provides software and pharmacy solutions for veterinary practices, including an integrated platform that manages prescription workflows, online pharmacy storefronts with home delivery, and compounded medication services.

HealthtechMedical DevicesSaaS

Co-investorsHarbor Light Capital PartnersMountain Group CapitalBorealis VenturesClayton Dubilier & RiceHLM Investment PartnersRock Springs Capital+1 more

Vitagenevitagene.com

Vitagene offers at-home test kits that analyze DNA, inflammation markers, and other health indicators, delivering results online in plain language.

Digital HealthDirect to ConsumerHealthtechWellness & FitnessSan Francisco, US

Mehdi Maghsoodnia(Executive Officer, Director)inReza Malek(Executive Officer, Director)

BoardLyon Wong(Director)

Co-investorsBabel VenturesPlug and Play Ventures

Voyadovoyado.comin

Voyado provides AI-powered customer engagement, product discovery, and loyalty solutions for retailers to increase revenue.

AI & Machine LearningMarketing TechRetail TechSaaSNorrköping, SE

Mikael Selegård(Founder)inErica Sandelin Ekelundin

Co-investorseEquity ABViking GlobalVerdane

Xcell BiosciencesinJan 2022

BiotechSan Francisco, US

Kaz Ohno(Executive Officer)James Lim(Executive Officer)Brian S. Feth(Executive Officer, Director)

BoardSaeid Akhtari(Director)

Co-investorsCasdin CapitalDynamk CapitalFormic Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AmplifyBioAuris Surgical RoboticsGT Medical TechnologiesHumanevaJazzwareMotif FoodWorksPavia Systems

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.